HALOZYME THERAPEUTICS INC

CUSIP: 40637HAF6 Class: NOTE 1.000% 8/1

SHENKMAN CAPITAL MANAGEMENT INC's Holding History (CIK: 0001275228)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 900,000 Value ($000) $1,268 Avg Close — Range —
Q2 2025
Shares 4,204,000 Value ($000) $5,331 Avg Close — Range —
Q1 2025
Shares 7,151,000 Value ($000) $9,426 Avg Close — Range —
Q4 2024
Shares 11,950,000 Value ($000) $13,622 Avg Close — Range —
Q3 2024
Shares 5,570,000 Value ($000) $6,720 Avg Close — Range —
Q2 2024
Shares 5,482,000 Value ($000) $6,246 Avg Close — Range —
Q1 2024
Shares 5,526,000 Value ($000) $5,520 Avg Close — Range —
Q4 2023
Shares 5,224,000 Value ($000) $4,953 Avg Close — Range —
Q3 2023
Shares 4,186,000 Value ($000) $3,980 Avg Close — Range —